Stay updated on Lirentelimab in Eosinophilic Esophagitis Clinical Trial

Sign up to get notified when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner about NIH website updates and the transition from “Artificial Intelligence” to “Super Intelligence” was removed.
    Difference
    1%
    Check dated 2026-11-08T05:45:08.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.2 to v3.8.0. The study record page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T04:14:22.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T04:48:43.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T04:45:59.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T06:38:55.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    A 403 Forbidden message appears where the clinical study record would normally be displayed, so the study details are unavailable.
    Difference
    0.5%
    Check dated 2026-10-04T08:15:45.000Z thumbnail image

Stay in the know with updates to Lirentelimab in Eosinophilic Esophagitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.